| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 183.58M | — |
| Operating expense | — | — |
| Net income | -15.66M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 038.F returned +46.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +31.6% |
| 1 year | +46.2% |
| 5 years | -87.5% |
| 10 years | +110.3% |
| All-time high | €186.25 (Jun 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in 038.F would be worth today ›No. NovoCure Limited has not paid a dividend in the past 12 months.
NovoCure Limited is part of the Healthcare sector.
NovoCure Limited has a market cap of 1.64B EUR, based on the latest quote.
NovoCure Limited is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
